Lydia Pui Yee Loke

4PUBLICATIONS
10CO-AUTHORS
Respiratory diseasesGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 02, 2025
Cost-effectiveness of ruxolitinib in Singapore for patients with chronic graft-versus-host disease.

Naren Kumar Surendra, Jiamin Ong, Xin Yi Wong

|Feb 17, 2021
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore.

Li-Jen Cheng, Lydia Loke, Elaine Hsuen Lim

|Oct 21, 2020
Cost-effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore.

Lydia Loke, Soo-Chin Lee, Fiona Pearce

|May 29, 2020
Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer.

Mohamed Ismail Abdul Aziz, Ling Eng Tan, Wan Hui Gloria Tan

Pageof 1